ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OCPNY Olympus Corporation (PK)

18.00
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Olympus Corporation (PK) USOTC:OCPNY OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.00 0.00 01:00:00

Olympus: Gyrus Purchase Advisory Fee Not Unreasonably Expensive

27/10/2011 3:59am

Dow Jones News


Olympus (PK) (USOTC:OCPNY)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Olympus (PK) Charts.

Olympus Corp. (7733.TO) Thursday defended payments for controversial past acquisitions, saying financial advisory fees it paid in the purchase of U.K. medical technology firm Gyrus Group weren't excessive, and there was nothing illegal about the purchase of four firms.

"The fees were determined at the contract signing, so we do not believe they were unreasonably expensive," the company said in a statement.

The acquisitions in question involve a $687 million payout to a financial adviser based in the Cayman Islands for its assistance in the $1.9 billion purchase of Gyrus in 2008. However, the fees the company refers to in the statement don't include the bulk of the $687 million in question.

Olympus also bought three small Japanese companies for a total of Y73.49 billion ($966 million) between 2006 and 2008.

At a press conference Thursday, newly appointment President Shuichi Takayama defended the purchases, saying the acquisitions were all planned within the context of its medium- to long-term strategy.

On Wednesday, Takayama took over after Tsuyoshi Kikukawa, a 47-year veteran of the maker of cameras and medical-imaging equipment, resigned as chairman and president, citing investor and client concerns in the two weeks since he dismissed Chief Executive Michael Woodford.

But the scandal over expensive acquisitions and fees seems unlikely to be defused by Kikukawa's exit after Olympus lost more than half its market value since removing Woodford Oct. 14.

-By Juro Osawa and Kana Inagaki, Dow Jones Newswires; 813 6269 2794; juro.osawa@dowjones.com

1 Year Olympus (PK) Chart

1 Year Olympus (PK) Chart

1 Month Olympus (PK) Chart

1 Month Olympus (PK) Chart

Your Recent History

Delayed Upgrade Clock